Skip to main content
placeholder image

ZD6474 versus gefitinib in patients with advanced NSCLC: Final results from a two-part, double-blind, randomized phase II trial

Journal Article


Abstract


Publication Date


  • 2006

Citation


  • Natale, R. B., Bodkin, D., Govindan, R., Sleckman, B., Rizvi, N., Capo, A., . . . Ranson, M. (2006). ZD6474 versus gefitinib in patients with advanced NSCLC: Final results from a two-part, double-blind, randomized phase II trial. Journal of Clinical Oncology, 24(18_suppl), 7000. doi:10.1200/jco.2006.24.18_suppl.7000

Web Of Science Accession Number


Start Page


  • 7000

End Page


  • 7000

Volume


  • 24

Issue


  • 18_suppl

Abstract


Publication Date


  • 2006

Citation


  • Natale, R. B., Bodkin, D., Govindan, R., Sleckman, B., Rizvi, N., Capo, A., . . . Ranson, M. (2006). ZD6474 versus gefitinib in patients with advanced NSCLC: Final results from a two-part, double-blind, randomized phase II trial. Journal of Clinical Oncology, 24(18_suppl), 7000. doi:10.1200/jco.2006.24.18_suppl.7000

Web Of Science Accession Number


Start Page


  • 7000

End Page


  • 7000

Volume


  • 24

Issue


  • 18_suppl